John T. Toole
2006
In 2006, John T. Toole earned a total compensation of $2.4M as Senior Vice President, Clinical Research at Gilead Sciences.
Compensation breakdown
| Non-Equity Incentive Plan | $205,350 |
|---|---|
| Option Awards | $1,836,610 |
| Salary | $368,333 |
| Other | $3,435 |
| Total | $2,413,728 |
Toole received $1.8M in option awards, accounting for 76% of the total pay in 2006.
Toole also received $205.4K in non-equity incentive plan, $368.3K in salary and $3.4K in other compensation.
Rankings
In 2006, John T. Toole's compensation ranked 1,417th out of 7,022 executives tracked by ExecPay. In other words, Toole earned more than 79.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,417 out of 7,022 | 80th |
Division Manufacturing | 444 out of 2,413 | 82nd |
Major group Chemicals And Allied Products | 80 out of 673 | 88th |
Industry group Drugs | 44 out of 518 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 7 out of 112 | 94th |
Source: SEC filing on March 22, 2007.
Toole's colleagues
We found four more compensation records of executives who worked with John T. Toole at Gilead Sciences in 2006.